Plain Prescription Prices Act

Hozzl · 2025-07-31T04:23:22Z

Explore the details of House Bill 4623 Plain Prescription Prices Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

7/31/2025, 4:23 AM

Summary of Bill HR 4623

This bill, designated as H.R. 4623 in the 119th Congress and introduced on July 22, 2025, aims to mandate direct-to-consumer advertisements for prescription drugs and biological products to incorporate accurate and non-deceptive pricing details.

Congressional Summary of HR 4623

Plain Prescription Prices Act

This bill requires the Centers for Medicare & Medicaid Services to issue a rule requiring direct-to-consumer television advertisements for prescription drugs that are covered by Medicare or Medicaid to include a textual statement of the drug's list price.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4623

Bill HR 4623 is currently in the status of Bill Introduced since July 22, 2025. Bill HR 4623 was introduced during Congress 119 and was introduced to the House on July 22, 2025. Bill HR 4623's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of July 22, 2025

Bipartisan Support of Bill HR 4623

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4623

Primary Policy Focus

Alternate Title(s) of Bill HR 4623

To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.